Our Approach

We believe in listening—to people and to everyday life. That principle guides how we design AI, shaped by three core commitments:

1. Pre-screening First
Instead of replacing medical care, we provide a foundation for awareness that helps people choose when to seek care, testing, or preventive action.

2. Clinical by Design
Every AI we build is grounded in data collected in clinical settings, with reliability validated through rigorous clinical research.

3. Human-Centered & Respectful
We design experiences that naturally fit into daily life, while respecting cultural values and protecting privacy.

Global Health Initiatives

Our AI analyzes cough, breathing, and voice patterns captured through smartphones to reveal early signs that often go unnoticed. Building on this unified approach, we address diverse health challenges across regions.

1. Africa | Listening to TB

Tuberculosis remains one of the world’s deadliest infectious diseases, and in many African regions, delayed detection continues to drive transmission. We are designing an approach that identifies at-risk individuals and communities by analyzing subtle changes in cough and breathing sounds. This enables national TB programs to prioritize areas where active screening is most needed — supporting more efficient testing and reducing diagnostic delays, ultimately helping to curb the spread of infection.

2. Middle East | Listening to Lifestyle & Respiratory Risks

In the Middle East, diabetes and other blood glucose–related disorders have become major health challenges, often coexisting with respiratory conditions such as sleep apnea, pneumonia, and lung cancer. Smoking is also widespread in the region, further increasing the strain on respiratory health. Our AI focuses on detecting early signs linked to both blood glucose fluctuations and respiratory changes — helping people recognize risks sooner, take preventive action, and maintain healthier, longer lives.

3. Japan & Beyond | Listening to Everyday

Health In Japan, we have developed AI tools focused on sleep, already implemented in corporate and institutional health programs — forming a solid foundation for global deployment. At the same time, research on cough detection is underway, while a new AI that captures swallowing motions is expected to be completed within this year. Our ongoing work on sleep-stage analysis also opens new possibilities for understanding neurodevelopmental and neurological conditions that have been difficult to visualize before.

Through these initiatives, we aim to deliver diverse forms of early awareness across the world — empowering people and communities to take action before illness takes hold.

Technology

Our AI is designed around three core principles — clinical accuracy, everyday usability, and global scalability.  

1. Clinical-Grade Accuracy

Developed using data collected in real clinical settings and validated for reliability. Rather than replacing medical devices, it supports Pre-screening — helping people notice early signs before conditions become serious.

2. Frictionless Experience

Works with just a smartphone — no needles, no tubes, no attachments. Completely non-invasive and privacy-conscious, it blends naturally into daily life while providing valuable health insights.

3. Scalable by Design

Because analysis is performed in the cloud, accuracy remains consistent across locations. The system can be easily expanded to new diseases and continuously updated, enabling truly global deployment.

Impact We Aim For

Our goal is not simply technological advancement — but the social impact created through greater health awareness.

・Individual level — Helping people notice changes in their own bodies earlier, empowering them to take care of their health and future.

・Societal level — Reducing delayed consultations and unnecessary testing, improving the efficiency and accessibility of healthcare resources.

・Future level — Preventing severe and chronic illnesses over time, extending healthy life expectancy and building a more sustainable healthcare foundation.

AMIKAKE AI serves as an infrastructure for awareness — a system designed to generate these layered impacts across individuals, societies, and generations.

Proof & Partners

Founded in 2025, AMIKAKE AI is a young company built on years of prior experience in international exhibitions, research, and AI validation. Drawing on this foundation, we continue to advance clinical studies and global collaborations with medical institutions, corporations, and regulators.

Key Collaborations & Achievements
・Kobe University — Joint clinical studies on sleep apnea, sleep stages, and cough detection
・Showa University — Joint clinical research on oral functions, including swallowing and tongue pressure
・Fujifilm — Co-developing a clinical tuberculosis project in Africa
・Dubai Health — Preparing a clinical joint study on lifestyle-related diseases
・MOHAP (UAE Ministry of Health & Prevention) — Officially classified a sleep AI app as a non-invasive, software-only medical application, recognizing the team’s earlier achievement in healthtech innovation
・Sleep AI deployed in workplace and corporate health programs
・Featured in Forbes JAPAN for innovation

Company Overview & Contact

Company Name: AMIKAKE AI Inc.
Established: 2025
Representative: Ayumi Hata, Founder & CEO
Head Office: 5th Floor, 3-16-12 Roppongi, Minato-ku, Tokyo 106-0032, Japan
Business Scope: Global development and deployment of AI-based pre-screening technologies

For updates and collaborations:
・[AMIKAKE AI — Company Page on LinkedIn]
・[Ayumi Hata (Founder & CEO) — LinkedIn]